{"id":752058,"date":"2023-04-27T09:21:39","date_gmt":"2023-04-27T13:21:39","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/eqrx-to-hold-first-quarter-2023-financial-results-conference-call-on-monday-may-8-2023\/"},"modified":"2023-04-27T09:21:39","modified_gmt":"2023-04-27T13:21:39","slug":"eqrx-to-hold-first-quarter-2023-financial-results-conference-call-on-monday-may-8-2023","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/eqrx-to-hold-first-quarter-2023-financial-results-conference-call-on-monday-may-8-2023\/","title":{"rendered":"EQRx to Hold First Quarter 2023 Financial Results Conference Call on Monday, May 8, 2023"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"left\">CAMBRIDGE, Mass., April  27, 2023  (GLOBE NEWSWIRE) &#8212; <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=HlSlIE4zREItyc84eOvbjXztHSy977LaXt1KyFt5LD6LqVfUpX-U0MiJBxKUE7Qsda99LB7Goo62IMw2rlV6VQ==\" rel=\"nofollow noopener\" target=\"_blank\">EQRx, Inc.<\/a> (Nasdaq: EQRX), a new type of pharmaceutical company committed to developing and expanding access to innovative medicines for some of the most prevalent disease areas, including cancer and immune-inflammatory conditions, today announced it will host a conference call and webcast on Monday, May 8, 2023, at 4:30 p.m. ET to report its first quarter 2023 financial results and provide a business update.<\/p>\n<p>A live webcast of the call will be available on the \u201cInvestor Relations\u201d page of the Company\u2019s website at https:\/\/investors.eqrx.com\/news-events\/events-presentations. To access the call by phone, participants should visit this link (<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=qoYvEDOOcB7jBl4dqvHgMD6GNTSuutRUvmYRZo7LTilVYAZi_upEkxkS0vDhtIOX7klnl8DbEQI-Q5RaB1MossyUmt__pEQw9boplRTJGH5a3ELYnZw6cUfJ9xfUxbyeCK_isA4sOMpUnUMWdReqkA==\" rel=\"nofollow noopener\" target=\"_blank\">registration link<\/a>) to receive dial-in details. Participants are requested to register at least 15 minutes before the start of the call. The webcast will be made available for replay on the Company\u2019s website beginning approximately two hours after the event.<\/p>\n<p>\n        <strong>About EQRx<\/strong><br \/>\n        <br \/>EQRx is a new type of pharmaceutical company committed to developing and expanding access to innovative medicines for some of the most prevalent disease areas, including cancer and immune-inflammatory conditions. Launched in January 2020, EQRx is leveraging cutting-edge science, technology and strategic partnerships with stakeholders from across the healthcare system toward the goal of increasing access for patients around the world. To learn more, visit www.eqrx.com and follow us on social media: Twitter: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=c_ILokq-0Ff7hABSDSebR6_62B7GOdkr0TN6ycw3_ArQxj7tAnsVDx6igS4a95tu3X-9pJi_64EZ-Alx0Ragtg==\" rel=\"nofollow noopener\" target=\"_blank\">@EQRx_US<\/a>, <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=ruMWDNSF6iNTuoPHeoXg3lgBV4EwQNrfzAaP3ORe53leK2RRAMYUp_GOPmuGiazFBXNEM7zEzT676pcSi6zMukGre41bYj2etr_Srvukec0=\" rel=\"nofollow noopener\" target=\"_blank\">LinkedIn<\/a>.<\/p>\n<p>EQRx\u2122 and Remaking Medicine\u2122 are trademarks of EQRx.<\/p>\n<p>\n        <strong>EQRx Contacts: <\/strong>\n      <\/p>\n<p>Media:<br \/>Dan Budwick <br \/>1AB<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=okAODBxz6580ygGNTLx2jJupA7i97b0ml1TpM71tqZmDrG0zx8LxHB4eGzTMVft0bKLRrA60T6TVl1gWqgU8jg==\" rel=\"nofollow noopener\" target=\"_blank\">dan@1abmedia.com<\/a><\/p>\n<p>Investors:<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Z3jwbd-4zKT926HmQdx6DBkN8X8RTklvIRUQM58yDgyLZxI7qawmBGxTS5GBTQEm_4MmiQOCUtBebO6tNS5-yu7YDGoHaciOl0WlobvwWJQ=\" rel=\"nofollow noopener\" target=\"_blank\">investors@eqrx.com<\/a><\/p>\n<p \/>\n      <img decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgyNjUxNSM1NTU5NjQ0IzIyMjIwMzE=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" src=\"https:\/\/ml.globenewswire.com\/media\/ZDcyYTQ0N2QtMDAwYi00NWFjLWEwNzMtNjM4YWUzMDc0MTY4LTEyMzM1ODQ=\/tiny\/EQRx-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>CAMBRIDGE, Mass., April 27, 2023 (GLOBE NEWSWIRE) &#8212; EQRx, Inc. (Nasdaq: EQRX), a new type of pharmaceutical company committed to developing and expanding access to innovative medicines for some of the most prevalent disease areas, including cancer and immune-inflammatory conditions, today announced it will host a conference call and webcast on Monday, May 8, 2023, at 4:30 p.m. ET to report its first quarter 2023 financial results and provide a business update. A live webcast of the call will be available on the \u201cInvestor Relations\u201d page of the Company\u2019s website at https:\/\/investors.eqrx.com\/news-events\/events-presentations. To access the call by phone, participants should visit this link (registration link) to receive dial-in details. Participants are requested to register at least 15 minutes before the &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/eqrx-to-hold-first-quarter-2023-financial-results-conference-call-on-monday-may-8-2023\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;EQRx to Hold First Quarter 2023 Financial Results Conference Call on Monday, May 8, 2023&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-752058","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>EQRx to Hold First Quarter 2023 Financial Results Conference Call on Monday, May 8, 2023 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/eqrx-to-hold-first-quarter-2023-financial-results-conference-call-on-monday-may-8-2023\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"EQRx to Hold First Quarter 2023 Financial Results Conference Call on Monday, May 8, 2023 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"CAMBRIDGE, Mass., April 27, 2023 (GLOBE NEWSWIRE) &#8212; EQRx, Inc. (Nasdaq: EQRX), a new type of pharmaceutical company committed to developing and expanding access to innovative medicines for some of the most prevalent disease areas, including cancer and immune-inflammatory conditions, today announced it will host a conference call and webcast on Monday, May 8, 2023, at 4:30 p.m. ET to report its first quarter 2023 financial results and provide a business update. A live webcast of the call will be available on the \u201cInvestor Relations\u201d page of the Company\u2019s website at https:\/\/investors.eqrx.com\/news-events\/events-presentations. To access the call by phone, participants should visit this link (registration link) to receive dial-in details. Participants are requested to register at least 15 minutes before the &hellip; Continue reading &quot;EQRx to Hold First Quarter 2023 Financial Results Conference Call on Monday, May 8, 2023&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/eqrx-to-hold-first-quarter-2023-financial-results-conference-call-on-monday-may-8-2023\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2023-04-27T13:21:39+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgyNjUxNSM1NTU5NjQ0IzIyMjIwMzE=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/eqrx-to-hold-first-quarter-2023-financial-results-conference-call-on-monday-may-8-2023\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/eqrx-to-hold-first-quarter-2023-financial-results-conference-call-on-monday-may-8-2023\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"EQRx to Hold First Quarter 2023 Financial Results Conference Call on Monday, May 8, 2023\",\"datePublished\":\"2023-04-27T13:21:39+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/eqrx-to-hold-first-quarter-2023-financial-results-conference-call-on-monday-may-8-2023\\\/\"},\"wordCount\":256,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/eqrx-to-hold-first-quarter-2023-financial-results-conference-call-on-monday-may-8-2023\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODgyNjUxNSM1NTU5NjQ0IzIyMjIwMzE=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/eqrx-to-hold-first-quarter-2023-financial-results-conference-call-on-monday-may-8-2023\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/eqrx-to-hold-first-quarter-2023-financial-results-conference-call-on-monday-may-8-2023\\\/\",\"name\":\"EQRx to Hold First Quarter 2023 Financial Results Conference Call on Monday, May 8, 2023 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/eqrx-to-hold-first-quarter-2023-financial-results-conference-call-on-monday-may-8-2023\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/eqrx-to-hold-first-quarter-2023-financial-results-conference-call-on-monday-may-8-2023\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODgyNjUxNSM1NTU5NjQ0IzIyMjIwMzE=\",\"datePublished\":\"2023-04-27T13:21:39+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/eqrx-to-hold-first-quarter-2023-financial-results-conference-call-on-monday-may-8-2023\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/eqrx-to-hold-first-quarter-2023-financial-results-conference-call-on-monday-may-8-2023\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/eqrx-to-hold-first-quarter-2023-financial-results-conference-call-on-monday-may-8-2023\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODgyNjUxNSM1NTU5NjQ0IzIyMjIwMzE=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODgyNjUxNSM1NTU5NjQ0IzIyMjIwMzE=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/eqrx-to-hold-first-quarter-2023-financial-results-conference-call-on-monday-may-8-2023\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"EQRx to Hold First Quarter 2023 Financial Results Conference Call on Monday, May 8, 2023\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"EQRx to Hold First Quarter 2023 Financial Results Conference Call on Monday, May 8, 2023 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/eqrx-to-hold-first-quarter-2023-financial-results-conference-call-on-monday-may-8-2023\/","og_locale":"en_US","og_type":"article","og_title":"EQRx to Hold First Quarter 2023 Financial Results Conference Call on Monday, May 8, 2023 - Market Newsdesk","og_description":"CAMBRIDGE, Mass., April 27, 2023 (GLOBE NEWSWIRE) &#8212; EQRx, Inc. (Nasdaq: EQRX), a new type of pharmaceutical company committed to developing and expanding access to innovative medicines for some of the most prevalent disease areas, including cancer and immune-inflammatory conditions, today announced it will host a conference call and webcast on Monday, May 8, 2023, at 4:30 p.m. ET to report its first quarter 2023 financial results and provide a business update. A live webcast of the call will be available on the \u201cInvestor Relations\u201d page of the Company\u2019s website at https:\/\/investors.eqrx.com\/news-events\/events-presentations. To access the call by phone, participants should visit this link (registration link) to receive dial-in details. Participants are requested to register at least 15 minutes before the &hellip; Continue reading \"EQRx to Hold First Quarter 2023 Financial Results Conference Call on Monday, May 8, 2023\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/eqrx-to-hold-first-quarter-2023-financial-results-conference-call-on-monday-may-8-2023\/","og_site_name":"Market Newsdesk","article_published_time":"2023-04-27T13:21:39+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgyNjUxNSM1NTU5NjQ0IzIyMjIwMzE=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/eqrx-to-hold-first-quarter-2023-financial-results-conference-call-on-monday-may-8-2023\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/eqrx-to-hold-first-quarter-2023-financial-results-conference-call-on-monday-may-8-2023\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"EQRx to Hold First Quarter 2023 Financial Results Conference Call on Monday, May 8, 2023","datePublished":"2023-04-27T13:21:39+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/eqrx-to-hold-first-quarter-2023-financial-results-conference-call-on-monday-may-8-2023\/"},"wordCount":256,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/eqrx-to-hold-first-quarter-2023-financial-results-conference-call-on-monday-may-8-2023\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgyNjUxNSM1NTU5NjQ0IzIyMjIwMzE=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/eqrx-to-hold-first-quarter-2023-financial-results-conference-call-on-monday-may-8-2023\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/eqrx-to-hold-first-quarter-2023-financial-results-conference-call-on-monday-may-8-2023\/","name":"EQRx to Hold First Quarter 2023 Financial Results Conference Call on Monday, May 8, 2023 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/eqrx-to-hold-first-quarter-2023-financial-results-conference-call-on-monday-may-8-2023\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/eqrx-to-hold-first-quarter-2023-financial-results-conference-call-on-monday-may-8-2023\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgyNjUxNSM1NTU5NjQ0IzIyMjIwMzE=","datePublished":"2023-04-27T13:21:39+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/eqrx-to-hold-first-quarter-2023-financial-results-conference-call-on-monday-may-8-2023\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/eqrx-to-hold-first-quarter-2023-financial-results-conference-call-on-monday-may-8-2023\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/eqrx-to-hold-first-quarter-2023-financial-results-conference-call-on-monday-may-8-2023\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgyNjUxNSM1NTU5NjQ0IzIyMjIwMzE=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgyNjUxNSM1NTU5NjQ0IzIyMjIwMzE="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/eqrx-to-hold-first-quarter-2023-financial-results-conference-call-on-monday-may-8-2023\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"EQRx to Hold First Quarter 2023 Financial Results Conference Call on Monday, May 8, 2023"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/752058","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=752058"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/752058\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=752058"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=752058"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=752058"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}